Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Kidney & Blood Pressure Research|March 28, 2021
The COVID-19 Epidemic: Management and Outcomes of Hemodialysis and Peritoneal Dialysis Patients in Stockholm, SwedenJessica Smolander, Annette BruchfeldClinical Kidney Journal|June 23, 2017
B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritisSigrid Lundberg, Emelie Westergren, Jessica Smolander, et al.Nephron. Clinical Practice|November 18, 2014
Rituximab in adult minimal change disease and focal segmental glomerulosclerosisAndreas Kronbichler, Annette BruchfeldClinical Kidney Journal|April 25, 2024
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney diseaseVanja Ivković, Annette BruchfeldSeminars in Dialysis|November 27, 2018
Direct acting anti-viral medications for hepatitis C: Clinical trials in patients with advanced chronic kidney diseaseAnnette Bruchfeld, Karin LindahlNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2020
The cholinergic anti-inflammatory pathway in chronic kidney disease-review and vagus nerve stimulation clinical pilot studyMarie Hilderman, Annette BruchfeldFrontiers in Immunology|February 10, 2016
Macrophage Migration Inhibitory Factor in Clinical Kidney DiseaseAnnette Bruchfeld, Mårten Wendt, Edmund J MillerTransplantation|September 17, 2004
Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantationAnnette Bruchfeld, Henryk Wilczek, Carl-Gustaf ElinderHepatology (Baltimore, Md.)|January 22, 2005
High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis CKarin Lindahl, Lars Stahle, Annette Bruchfeld, et al.Pageof 14